709,484 Shares in Cigna Group $CI Acquired by Caisse de depot et placement du Quebec

Caisse de depot et placement du Quebec purchased a new stake in shares of Cigna Group (NYSE:CI) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 709,484 shares of the health services provider’s stock, valued at approximately $195,591,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at $25,000. Osbon Capital Management LLC bought a new position in shares of Cigna Group in the second quarter valued at about $26,000. Cedar Mountain Advisors LLC lifted its position in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Cigna Group during the 2nd quarter worth about $29,000. Finally, Fiduciary Financial Advisors acquired a new stake in Cigna Group in the 2nd quarter valued at about $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

Cigna Group stock opened at $281.01 on Thursday. The firm has a market capitalization of $74.25 billion, a P/E ratio of 11.63, a PEG ratio of 0.96 and a beta of 0.29. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The business has a 50-day moving average of $283.58 and a 200-day moving average of $281.51. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period last year, the company posted $7.20 EPS. Cigna Group’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts anticipate that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 23,012 shares of company stock valued at $6,386,550 in the last three months. 0.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

CI has been the subject of a number of research analyst reports. Royal Bank Of Canada boosted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Piper Sandler lowered their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Finally, Robert W. Baird set a $362.00 target price on Cigna Group in a research report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.